Home Newsfeeds Oppenheimer Initiates Coverage On BigCommerce Holdings with Perform Rating

Oppenheimer Initiates Coverage On BigCommerce Holdings with Perform Rating

Oppenheimer analyst Ken Wong initiates coverage on BigCommerce Holdings (NASDAQ:BIGC) with a Perform rating.

byBenzinga Newsdesk

July 27, 2022

1 minute read

Oppenheimer analyst Ken Wong initiates coverage on BigCommerce Holdings (NASDAQ:BIGC) with a Perform rating.

Analyst Ratings

What 10 Analyst Ratings Have To Say About Trane Technologies

By Benzinga Insights

September 15, 9:01 AM

Within the last quarter, Trane Technologies (NYSE:TT) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

Middlesex Water Q3 EPS $0.80 Up From $0.65 YoY, Sales $47.73M Up From $39.87M YoY

By Michael Horton

October 28, 4:21 PM

Middlesex Water (NASDAQ:MSEX) reported quarterly earnings of $0.80 per share. This is a 23.08 percent increase over earnings of $0.65 per share from the same period last year. The company reported $47.73 million in

MSEX

Antero Midstream Authorizes A $500M Share Repurchase Program

By Benzinga Newsdesk

February 14, 6:00 PM

Share Repurchase ProgramOn February 14, 2024, Antero Midstream's Board of Directors authorized a share repurchase program that allows the Company to repurchase up to $500 million of outstanding common stock. This

Why NLS Pharmaceutics (NLSP) Stock Is Down 40% Today

By Henry Khederian

November 16, 12:00 PM

NLS Pharmaceutics AG (NASDAQ: NLSP) shares are trading lower by 40% to $0.30 Thursday morning after the company announced it is seeking strategic alternatives to enhance shareholder value by exploring partnerships, licensing its intellectual property and implementing

NLSP

Oppenheimer Initiates Coverage On BigCommerce Holdings with Perform Rating

Related Posts

What 10 Analyst Ratings Have To Say About Trane Technologies

Middlesex Water Q3 EPS $0.80 Up From $0.65 YoY, Sales $47.73M Up From $39.87M YoY

Antero Midstream Authorizes A $500M Share Repurchase Program

Why NLS Pharmaceutics (NLSP) Stock Is Down 40% Today